Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Changes To Retirement Age And Access To Superannuation Can Have Adverse Affects For Many Workers Including Nurses
The ANF calls on the Prime Minister to consult with nurses and other occupations that are most affected before implementing changes to the retirement age for pensions or superannuation.
generic viagra online
University Of Southern California Faculty Present Cancer Research At ASCO Annual Meeting
Researchers at the University of Southern California (USC) and USC Norris Comprehensive Cancer Center will present breakthrough research in a number of researchstudy areas at the 2009 American Society of Clinical Oncology (ASCO) annual meeting in Orlando, Florida.
News of the day
La. Gov. Jindal Signs Law Expanding Protections For Health Workers Who Refuse Services
Louisiana Gov. Bobby Jindal (R) on Tuesday signed into law a bill (HB 517) that expands health care provider "conscience" protections beyond abortion to also include refusals to provide emergency contraception or participate in certain other procedures, the New Orleans Times-Picayune reports. The law provides job protection and legal immunity to "any person" who refuses to provide abortion services, distribute "abortifacient drugs," work on research involving embryonic stem cells or cloning, or participate in physician-assisted suicide or euthanasia. According to the Times-Picayune, the provision that refers to abortifacient drugs is intended to include EC but not other forms of birth control.Jindal"s administration said the law is necessary to protect the individual rights of doctors, nurses, pharmacists and other health care workers whose personal beliefs might conflict with their professional duties. Opponents of the law, including the Planned Parenthood Federation of America and the American Civil Liberties Union, argue that it will restrict patient access to accurate information and timely services (Barrow/Anderson, New Orleans Times-Picayune, 7/8).
Medical Devices

Evidence Challenges Effectiveness Of Embryo Screening For Older Women

There is growing evidence that a procedure for identifying chromosomal abnormalities in embryos prior to in vitro fertilization is ineffective at helping older women become pregnant, the Wall Street Journal reports. The procedure -- known as pre-implantation genetic screening, or PGS -- is performed in dozen of U.S. fertility clinics and sometimes marketed to older women as a way to increase the odds of a healthy live birth. PGS involves extracting a single cell from a six-cell embryo and inspecting it for chromosomal abnormalities known as aneuploidies; unaffected embryos can then be implanted through IVF. Women older than age 35 have a higher risk of aneuploidies, in which embryos have fewer or more than the usual number of 23 pairs of chromosomes. Aneuploidies can trigger early miscarriage or certain genetics conditions, such as Down syndrome. Most medical experts agree that embryo screening is capable of significantly reducing the risk of Down syndrome and other serious chromosome-related illnesses. However, evidence from several studies increasingly suggests that the procedure does not increase older women"s chances of healthy live births. The American Society for Reproductive Medicine released an initial opinion about PGS in 2007, saying that available evidence does not support the use of embryo screening to increase live birth rates in older women. Andrew La Barbera, scientific director of the society, said, "Since that time, there have been several more trials that have reached the same conclusion." Another shortcoming is that most clinics can only test for fewer than half of the 23 chromosomes, meaning that many defects can go undetected. However, medical experts say that the use of PGS has increased in the two years since ASRM issued its recommendations. According to the Journal, PGS can add more than $2,000 to the roughly $10,000 cost of one IVF cycle. Very few health insurers cover PGS, though some pay for IVF. Some experts contend that studies showing a lack of clinical benefit from PGS do not use more efficient biopsy techniques that can prevent damage to the embryo. Santiago Munne, scientific director for Reprogenetics, said that the treatment is "effective." In a 2007 study, Munne and colleagues used PGS to reduce the rate at which patients miscarried. However, the chances of a woman getting pregnant largely were unchanged, which the authors said could be attributed to the small number of study participants (Naik, Wall Street Journal, 6/1). Reprinted with kind permission from http://www.nationalpartnership.org. You can view the entire Daily Women"s Health Policy Report, search the archives, or sign up for email delivery here. The Daily Women"s Health Policy Report is a free service of the National Partnership for Women & Families, published by The Advisory Board Company. © 2009 The Advisory Board Company. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009